Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
Olotu, A; Lusingu, J; Leach, A; Lievens, M; Vekemans, J; Msham, S; Lang, T; Gould, J; Dubois, M-C; Jongert, E; Vansadia, P; Carter, T; Njuguna, P; Awuondo, KO; Malabeja, A; Abdul, O; Gesase, S; Mturi, N; DRAKELEY, CJ; Savarese, B; Villafana, T; Lapierre, D; Ballou, WR; Cohen, J; Lemnge, MM; ... Bejon, P.
2011
The Lancet infectious diseases, (2011).11 2 10.1016/S1473-3099(10)70262-0.
Protection against malaria by MSP3 candidate vaccine.
Sirima, SB; COUSENS, S; Druilhe, P;
2011
The New England journal of medicine, (2011).365 11 10.1056/NEJMc1100670.
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.
Russell, FM; Balloch, A; Licciardi, PV; Carapetis, JR; Tikoduadua, L; Waqatakirewa, L; Cheung, YB; MULHOLLAND, EK; Tang, ML K;
2011
Vaccine, (2011).29 27 10.1016/j.vaccine.2011.04.038.
BCG vaccination: a role for vitamin D?.
Lalor, MK; FLOYD, S; GORAK-STOLINSKA, P; Weir, RE; BLITZ, R; BRANSON, K; FINE, PE; DOCKRELL, HM;
2011
PloS one, (2011).6 1 10.1371/journal.pone.0016709.
Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort.
EAMES, KT D; Brooks-Pollock, E; Paolotti, D; Perosa, M; Gioannini, C; EDMUNDS, WJ;
2011
Epidemiology and infection, (2011).140 7 10.1017/S0950268811001804.
Another step down the development pipeline for the novel tuberculosis vaccine MVA-85A.
DOCKRELL, HM;
2011
The Journal of infectious diseases, (2011).203 12 10.1093/infdis/jir200.
Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative.
Jauregui, B; Sinha, A; CLARK, AD; Bolanos, BM; Resch, S; Toscano, CM; Matus, CR; Andrus, JK;
2011
Vaccine, (2011).29 5 10.1016/j.vaccine.2010.11.075.
Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.
Easton, A; Haque, A; Chu, K; Patel, N; Lukaszewski, RA; Krieg, AM; Titball, RW; BANCROFT, GJ;
2011
The Journal of infectious diseases, (2011).204 4 10.1093/infdis/jir301.
Long term trends introduce a potential bias when evaluating the impact of the pneumococcal conjugate vaccination programme in England and Wales.
FLASCHE, S; Slack, M; Miller, E;
2011
EUROSURVEILLANCE, (2011).16 20(20), Art.No. ARTN 19868, 13-18.
Incremental costs of introducing jet injection technology for delivery of routine childhood vaccinations: comparative analysis from Brazil, India, and South Africa.
GRIFFITHS, UK; SANTOS, AC; Nundy, N; Jacoby, E; Matthias, D;
2011
Vaccine, (2011).29 5 10.1016/j.vaccine.2010.11.038.